Berkshire Hathaway
ABBV icon

Berkshire Hathaway’s AbbVie ABBV Stock Holding History

Berkshire Hathaway’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,033,561
Closed -$411M – 50
2021
Q4 		$411M Sell
3,033,561
-11,364,927
-79% -$1.34B 0.12% 29
2021
Q3 		$1.55B Sell
14,398,488
-6,129,373
-30% -$700M 0.53% 20
2021
Q2 		$2.31B Sell
20,527,861
-2,340,317
-10% -$264M 0.79% 17
2021
Q1 		$2.47B Sell
22,868,178
-2,664,904
-10% -$285M 0.92% 15
2020
Q4 		$2.74B Buy
25,533,082
+4,268,766
+20% +$410M 1.01% 15
2020
Q3 		$1.86B Buy
+21,264,316
New +$2B 0.79% 17

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Berkshire Hathaway's ABBV Position: Q1 2022 in Review

Berkshire Hathaway sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 3,033,561 shares — an estimated $411M sold.

Berkshire Hathaway first reported a position in ABBV in Q3 2020 and held it in 6 quarters. The position peaked at $2.74B in Q4 2020. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

  • Berkshire Hathaway reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
  • Berkshire Hathaway sold 3,033,561 AbbVie shares in Q1 2022, an estimated $411M.
  • Berkshire Hathaway first reported a position in AbbVie in Q3 2020 and held it in 6 quarters.
  • Berkshire Hathaway's AbbVie position peaked at $2.74B in Q4 2020.
  • 3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Berkshire Hathaway's 13F filing for Q1 2022, filed 16 May 2022.